Wide-range ELISA Kit for Peroxiredoxin 2 (PRDX2)

PRP; NKEFB; PRXII; TDPX1; TSA; Thioredoxin-Dependent Peroxide Reductase 1; Thiol-Specific Antioxidant 1; Natural Killer-Enhancing Factor B; Thioredoxin Peroxidase 1; Torin

Specificity

This assay has high sensitivity and excellent specificity for detection of Wide-range Peroxiredoxin 2 (PRDX2).
No significant cross-reactivity or interference between Wide-range Peroxiredoxin 2 (PRDX2) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Wide-range Peroxiredoxin 2 (PRDX2) and the recovery rates were calculated by comparing the measured value to the expected amount of Wide-range Peroxiredoxin 2 (PRDX2) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-93 81
EDTA plasma(n=5) 99-105 102
heparin plasma(n=5) 79-103 92

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Wide-range Peroxiredoxin 2 (PRDX2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Wide-range Peroxiredoxin 2 (PRDX2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Wide-range Peroxiredoxin 2 (PRDX2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 94-103% 90-98% 89-97% 90-102%
EDTA plasma(n=5) 88-97% 80-101% 85-101% 92-101%
heparin plasma(n=5) 81-102% 97-105% 95-102% 93-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Free Radical Research Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress Pubmed:25564095
PLoS One Differences in Proinflammatory Property of Six Subtypes of Peroxiredoxins and Anti-Inflammatory Effect of Ligustilide in Macrophages pubmed:27716839
Experiental And Therapeutic Medicine Plasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription pubmed:28672924
Oncotarget Neuroprotective effect of a novel gastrodin derivative against ischemic brain injury: involvement of peroxiredoxin and TLR4 signaling inhibition pubmed:29207618
European Journal of Applied Physiology Prolonged forearm ischemia attenuates endothelium-dependent vasodilatation and plasma nitric oxide metabolites in overweight middle-aged men Pubmed:29785503
Journal of Applied Physiology Montmorency cherry supplementation attenuates vascular dysfunction induced by prolonged forearm occlusion in overweight middle-aged men Pubmed: 30496705
ACS Omega SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics 34250342
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPF757Hu02 Recombinant Peroxiredoxin 2 (PRDX2) Positive Control; Immunogen; SDS-PAGE; WB.
RPF757Hu03 Recombinant Peroxiredoxin 2 (PRDX2) Positive Control; Immunogen; SDS-PAGE; WB.
RPF757Hu01 Recombinant Peroxiredoxin 2 (PRDX2) Positive Control; Immunogen; SDS-PAGE; WB.
PAF757Hu01 Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) WB; IHC; ICC; IP.
PAF757Hu03 Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) WB; IHC; ICC; IP.
PAF757Hu02 Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) WB; IHC; ICC; IP.
MAF757Hu23 Monoclonal Antibody to Peroxiredoxin 2 (PRDX2) WB; IHC; ICC; IP.
MAF757Hu21 Monoclonal Antibody to Peroxiredoxin 2 (PRDX2) WB
WEF757Hu Wide-range ELISA Kit for Peroxiredoxin 2 (PRDX2) Enzyme-linked immunosorbent assay for Antigen Detection.
SEF757Hu ELISA Kit for Peroxiredoxin 2 (PRDX2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMF757Hu Multiplex Assay Kit for Peroxiredoxin 2 (PRDX2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.